TNM Cancer Staging System 5.1.1

Try before you buy - Download the Free App, which includes sample content. In-App purchase required to unlock all content.

The TNM Cancer Staging Manual is considered the definitive reference for oncologists, surgeons, pathologists, radiologists, cancer registrars, and medical professionals worldwide. Its aim is to ensure that all those involved in caring for cancer patients possess a comprehensive understanding of the language of cancer staging. This mobile resource offers Interactive TNM calculators that aid in the accurate classification and staging of various types of cancer.

Some of the cancer types covered include Breast cancer, Colon and Rectum, Distal Bile Duct, Liver, Neuroendocrine Tumors, Perihilar Bile Ducts, Stomach, and many others.

The TNM Cancer Staging Manual plays a crucial role for physicians and healthcare professionals globally as it promotes consistent description and reporting of neoplastic diseases. Proper classification and staging of cancer are essential for determining appropriate treatment, assessing management outcomes and clinical trials, and establishing the standard for local, regional, and international cancer reporting.

This edition has been significantly expanded and enhanced by international disease site expert panels. It highlights 12 entirely new staging systems, numerous updated or new staging definitions, and a heightened focus on personalized medicine.

The latest update includes general staging rules for clinical and pathological classifications, staging systems across various chapters, organization of T, N, M categories into distinct groups, histologic classifications and grading systems, WHO histology codes, more illustrations, and extensive updates to various topics such as Anus, Appendix, Brain and Spinal Cord, Cervix Uteri, NET Appendix - among others.

New paradigms introduced in this edition involve Human papillomavirus (HPV)-related oropharyngeal carcinoma staging systems based on HPV status and separate staging systems catering to patients with neoadjuvant therapy for esophagus and stomach cancers.

• Levels of evidence are now provided for revisions to staging systems
• Introduction of an imaging section
• Inclusion of Risk Assessment Models for select cancer sites
• Recommendations for Clinical Trial Stratification
• In-depth look at Prognostic factors including those required for prognostic stage grouping or recommended for clinical care
• Discussion on emerging factors affecting prognosis

New topics covered in this edition include Risk Assessment Models, Cervical Nodes and Unknown Primary Tumors of the Head and Neck, Oropharynx (HPV-Mediated - p16+), Cutaneous Carcinoma of the Head and Neck (including external lip), Thymus, Bone (Appendicular Skeleton/Trunk/Skull/Face), Pelvis, Spine Sarcoma stages in different body areas like head and neck or trunk), Parathyroid disorders, Leukemia classifications.

The content is licensed from the printed ISBN 10: 3319406175 and printed ISBN 13: 9783319406176.

SUBSCRIPTION: A yearly auto-renewing subscription is required to access content and receive updates. The cost for yearly auto-renewing payments is $79.99.

Payment will be charged to your iTunes Account upon purchase confirmation. The subscription will auto-renew unless turned off at least 24 hours before the current period ends. Users have the option to manage subscriptions through their device settings. Any unused portion of a free trial period will be forfeited upon subscription purchase.

If you have any inquiries or feedback, feel free to contact us via email at [email protected] or by phone at 508-299-3000.

• Privacy Policy - Privacy Policy
• Terms and Conditions - Terms and Conditions

Editor(s): Mahul B. Amin, MD, FCAP (Editor-in-Chief), Stephen B. Edge, MD, FACS, Frederick L. Greene, MD FACS et al.
Publisher: Springer-Verlag New York Inc.